These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 27026311)

  • 1. Predictive Parameters of Symptomatic Hematochezia Following 5-Fraction Gantry-Based SABR in Prostate Cancer.
    Musunuru HB; Davidson M; Cheung P; Vesprini D; Liu S; Chung H; Chu W; Mamedov A; Ravi A; D'Alimonte L; Commisso K; Helou J; Deabreu A; Zhang L; Loblaw A
    Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1043-51. PubMed ID: 27026311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose/volume relationship of late rectal bleeding after external beam radiotherapy for localized prostate cancer: absolute or relative rectal volume?
    Kupelian PA; Reddy CA; Carlson TP; Willoughby TR
    Cancer J; 2002; 8(1):62-6. PubMed ID: 11895204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of mean rectal dose on late rectal bleeding after conformal radiotherapy for prostate cancer: dose-volume effect.
    Zapatero A; García-Vicente F; Modolell I; Alcántara P; Floriano A; Cruz-Conde A; Torres JJ; Pérez-Torrubia A
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1343-51. PubMed ID: 15275719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer: further evidence for a significant dose effect.
    Lee WR; Hanks GE; Hanlon AL; Schultheiss TE; Hunt MA
    Int J Radiat Oncol Biol Phys; 1996 May; 35(2):251-7. PubMed ID: 8635930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rectal bleeding after hypofractionated radiotherapy for prostate cancer: correlation between clinical and dosimetric parameters and the incidence of grade 2 or worse rectal bleeding.
    Akimoto T; Muramatsu H; Takahashi M; Saito J; Kitamoto Y; Harashima K; Miyazawa Y; Yamada M; Ito K; Kurokawa K; Yamanaka H; Nakano T; Mitsuhashi N; Niibe H
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1033-9. PubMed ID: 15519772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: use of dose-volume constraints to achieve rectal isotoxicity.
    Vargas C; Yan D; Kestin LL; Krauss D; Lockman DM; Brabbins DS; Martinez AA
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):141-9. PubMed ID: 16111582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Phase II Trial of Stereotactic Ablative Radiation Therapy as a Boost for Locally Advanced Cervical Cancer.
    Albuquerque K; Tumati V; Lea J; Ahn C; Richardson D; Miller D; Timmerman R
    Int J Radiat Oncol Biol Phys; 2020 Mar; 106(3):464-471. PubMed ID: 31697990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy.
    Vargas C; Martinez A; Kestin LL; Yan D; Grills I; Brabbins DS; Lockman DM; Liang J; Gustafson GS; Chen PY; Vicini FA; Wong JW
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1297-308. PubMed ID: 16029785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rectal dose-volume constraints in high-dose radiotherapy of localized prostate cancer.
    Fiorino C; Sanguineti G; Cozzarini C; Fellin G; Foppiano F; Menegotti L; Piazzolla A; Vavassori V; Valdagni R
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(4):953-62. PubMed ID: 14575825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receiver operating curves and dose-volume analysis of late toxicity with stereotactic body radiation therapy for prostate cancer.
    Zhang L; Johnson J; Gottschalk AR; Chang AJ; Hsu IC; Roach M; Seymour ZA
    Pract Radiat Oncol; 2017; 7(2):e109-e116. PubMed ID: 28274401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results and DVH analysis of late rectal bleeding in patients treated with 3D-CRT or IMRT for localized prostate cancer.
    Someya M; Hori M; Tateoka K; Nakata K; Takagi M; Saito M; Hirokawa N; Hareyama M; Sakata K
    J Radiat Res; 2015 Jan; 56(1):122-7. PubMed ID: 25212601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose constraint for minimizing grade 2 rectal bleeding following brachytherapy combined with external beam radiotherapy for localized prostate cancer: rectal dose-volume histogram analysis of 457 patients.
    Shiraishi Y; Yorozu A; Ohashi T; Toya K; Seki S; Yoshida K; Kaneda T; Saito S; Nishiyama T; Hanada T; Shigematsu N
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e127-33. PubMed ID: 21398047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rectal toxicity after proton therapy for prostate cancer: an analysis of outcomes of prospective studies conducted at the university of Florida Proton Therapy Institute.
    Colaco RJ; Hoppe BS; Flampouri S; McKibben BT; Henderson RH; Bryant C; Nichols RC; Mendenhall WM; Li Z; Su Z; Morris CG; Mendenhall NP
    Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):172-81. PubMed ID: 25442338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetric predictors of toxicity and quality of life following prostate stereotactic ablative radiotherapy.
    Alayed Y; Davidson M; Quon H; Cheung P; Chu W; Chung HT; Vesprini D; Ong A; Chowdhury A; Liu SK; Panjwani D; Helou J; Musunuru HB; Pang G; Korol R; Ravi A; McCurdy B; Zhang L; Mamedov A; Deabreu A; Commisso A; Commisso K; D'Alimonte L; Ho L; Bhounr Z; Loblaw A
    Radiother Oncol; 2020 Mar; 144():135-140. PubMed ID: 31809979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SABR in High-Risk Prostate Cancer: Outcomes From 2 Prospective Clinical Trials With and Without Elective Nodal Irradiation.
    Alayed Y; Cheung P; Vesprini D; Liu S; Chu W; Chung H; Musunuru HB; Davidson M; Ravi A; Ho L; Deabreu A; D'Alimonte L; Bhounr Z; Zhang L; Commisso K; Loblaw A
    Int J Radiat Oncol Biol Phys; 2019 May; 104(1):36-41. PubMed ID: 30445172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Volume and hormonal effects for acute side effects of rectum and bladder during conformal radiotherapy for prostate cancer.
    Peeters ST; Hoogeman MS; Heemsbergen WD; Slot A; Tabak H; Koper PC; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1142-52. PubMed ID: 15939547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical effect of multileaf collimator width on the incidence of late rectal bleeding after high-dose intensity-modulated radiotherapy for localized prostate carcinoma.
    Inokuchi H; Mizowaki T; Norihisa Y; Takayama K; Ikeda I; Nakamura K; Nakamura M; Hiraoka M
    Int J Clin Oncol; 2016 Feb; 21(1):156-61. PubMed ID: 26164689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Efficacy of Stereotactic Ablative Radiation Therapy for Renal Cell Carcinoma Extracranial Metastases.
    Wang CJ; Christie A; Lin MH; Jung M; Weix D; Huelsmann L; Kuhn K; Meyer J; Desai N; Kim DWN; Pedrosa I; Margulis V; Cadeddu J; Sagalowsky A; Gahan J; Laine A; Xie XJ; Choy H; Brugarolas J; Timmerman R; Hannan R
    Int J Radiat Oncol Biol Phys; 2017 May; 98(1):91-100. PubMed ID: 28587057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rectal Hydrogel Spacer Improves Late Gastrointestinal Toxicity Compared to Rectal Balloon Immobilization After Proton Beam Radiation Therapy for Localized Prostate Cancer: A Retrospective Observational Study.
    Dinh TT; Lee HJ; Macomber MW; Apisarnthanarax S; Zeng J; Laramore GE; Rengan R; Russell KJ; Chen JJ; Ellis WJ; Schade GR; Liao JJ
    Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):635-643. PubMed ID: 32035187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-escalation of five-fraction SABR in prostate cancer: Toxicity comparison of two prospective trials.
    Musunuru HB; Quon H; Davidson M; Cheung P; Zhang L; D'Alimonte L; Deabreu A; Mamedov A; Loblaw A
    Radiother Oncol; 2016 Jan; 118(1):112-7. PubMed ID: 26796591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.